FY2022 | 3Q | Tokyo Stock Exchange 4934 |
Premier Anti-Aging Co., Ltd. | ||
June 13, 2022 | FY2022 3Q Results | |
INDEX
01 BUSINESS HIGHLIGHTS
- FY2022 FORECAST REVISION
- BUSINESS OVERVIEW
- INITIATIVES GOING FORWARD
- CLOSING REMARKS
- APPENDIX
Copyright©2022 PREMIER ANTI-AGING Co., Ltd. All Rights Reserved.
2
01 BUSINESS HIGHLIGHTS
Business Highlights
P&L Statement (YOY)
- Core brand DUO sales, especially in high-marginWholesale, declined due to slower-than-expected growth.
- DUO's profit was lower than expected, and operating profit declined as it could not absorb higher SG&A expenses such as advertising and system investments to strengthen growth in CANADEL and clayence.
Unit: Millions of Yen | ||||||||
FY2021 | FY2022 | Increase/ | YOY | |||||
1Q-3Q | 1Q-3Q | Decrease | ||||||
Net Sales | 23,766 | 25,896 | ＋2,130 | 109.0％ | ||||
ＬMail Order/EC | 15,940 | 17,868 | ＋1,928 | 112.1％ | ||||
ＬWholesale | 7,224 | 7,116 | △108 | 98.5％ | ||||
ＬOthers | 600 | 911 | ＋310 | 151.7％ | ||||
Operating Profit | 4,428 | 1,957 | △2,470 | 44.2％ | ||||
Operating Profit | 18.6％ | 7.6％ | △11.1pt | |||||
Margin | ||||||||
Ordinary Profit | 4,416 | 2,141 | △2,274 | 48.5％ | ||||
Profit attributable | 2,827 | 1,222 | △1,605 | 43.2％ | ||||
to Owners of the | ||||||||
Parent | ||||||||
Copyright©2022 PREMIER ANTI-AGING Co., Ltd. All Rights Reserved.
4
Business Highlights
SG&A (YOY)
- Advertising expenses increased due to new customer acquisition costs for mail-order sales and TV commercials.
- Consignment expenses increased due to variable costs linked to mail-order sales, which accounted for about half of the increase. The rest increased mainly due to system investment and overseas investment from 1Q to 2Q.
Unit: Millions of Yen | ||||||||
FY2021 | FY2022 | Increase/ | YOY | |||||
1Q-3Q | 1Q-3Q | Decrease | ||||||
SG&A | 14,809 | 18,704 | ＋3,894 | 126.3％ | ||||
ＬAdvertising & | 8,614 | 10,201 | ＋1,586 | 118.4％ | ||||
Promotion | ||||||||
ＬConsignment | 3,399 | 4,399 | ＋999 | 129.4％ | ||||
ＬSalaries & | 453 | 799 | ＋346 | 176.4％ | ||||
Allowances | ||||||||
ＬR&D | 118 | 310 | ＋192 | 262.7％ | ||||
ＬOthers | 2,223 | 2,993 | ＋770 | 134.6％ | ||||
Copyright©2022 PREMIER ANTI-AGING Co., Ltd. All Rights Reserved.
5
This is an excerpt of the original content. To continue reading it, access the original document here.